Darren Kelly

Managing Director at Certa Therapeutics Pty. Ltd.

Darren Kelly

Darren Kelly

Managing Director at Certa Therapeutics Pty. Ltd.

Overview
Career Highlights

Fibrotech Therapeutics Pty Ltd.
OccuRx Pty Ltd.

RelSci Relationships

3007

Number of Boards

1

Relationships
RelSci Relationships are individuals Darren Kelly likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founding Partner at Brandon Capital Partners Pty Ltd.

Relationship likelihood: Strong

Founding Partner at Brandon Capital Partners Pty Ltd.

Relationship likelihood: Strong

Investment Manager, Melbourne at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at GI Therapies Pty Ltd.

Relationship likelihood: Strong

Chief Financial Officer at Brandon Capital Partners Pty Ltd.

Relationship likelihood: Strong

Venture Partner at Brandon Capital Partners Pty Ltd.

Relationship likelihood: Strong

Executive Chairman at Seriosity, Inc.

Relationship likelihood: Strong

Venture Partner at Touchstone Innovations Ltd.

Relationship likelihood: Strong

Chief Executive Officer at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

Chief Financial Officer at Uniseed Management Pty Ltd.

Relationship likelihood: Strong

In The News
Australian Financial Review
May 17, 2017
457 blitz blocks whizkid from blindness cure trial
Paths to Darren Kelly
Potential Connections via
Relationship Science
You
Darren Kelly
Managing Director at Certa Therapeutics Pty. Ltd.
Education
MSc & PhD Diabetes
Class of 1998

Established in 1853, the University of Melbourne is a public-spirited institution that makes distinctive contributions to society in research, learning and teaching and engagement. It’s consistently ranked among the leading universities in the world, with international rankings of world universities placing it as number 1 in Australia and number 34 in the world (Times Higher Education World University Rankings 2013-2014).

Memberships
Member
Current

The Australian Institute of Company Directors (AICD) is a not-for-profit membership organisation for directors. The AICD is a founding member of the Global Network of Director Institutes (GNDI).

Member
Current
Member
Current

AusBiotech Ltd. is a private company headquartered in Melbourne, Australia, with domestic subsidiaries, that operates as a biotechnology membership company. It was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO since 2018.

Career History
Chief Executive Officer & Co-Founder
Current

OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia.

Managing Director
Current

Certa Therapeutics Pty Ltd. operates as biotechnology company. The firm develops drugs for treatment for kidney disease. The company was founded by Darren James Kelly and is headquartered in Melbourne, Australia.

Professor
Current

Established in 1853, the University of Melbourne is a public-spirited institution that makes distinctive contributions to society in research, learning and teaching and engagement. It’s consistently ranked among the leading universities in the world, with international rankings of world universities placing it as number 1 in Australia and number 34 in the world (Times Higher Education World University Rankings 2013-2014).

Boards & Committees
Chief Executive Officer & Director
2006 - Prior

Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia.

Investments
Details Hidden

Certa Therapeutics Pty Ltd. operates as biotechnology company. The firm develops drugs for treatment for kidney disease. The company was founded by Darren James Kelly and is headquartered in Melbourne, Australia.

Details Hidden

OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia.

Details Hidden

Fibrotech Therapeutics Pty Ltd develops novel drug candidates for the treatment of the fibrosis prevalent in such chronic conditions as kidney disease, chronic heart failure, pulmonary fibrosis, and arthritis. The company was founded by Richard Ernest Gilbert, Darren James Kelly, Spencer J Williams, Steven C Zammit, David Stapleton, Henry Krum and Yuan Zhang in 2006 and is headquartered in Melbourne, Australia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Darren Kelly. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Darren Kelly's profile does not indicate a business or promotional relationship of any kind between RelSci and Darren Kelly.